N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in Parkinson's disease models
{{output}}
N-acetyl-l-leucine (NALL), a derivative of the branched-chain amino acid leucine, has shown therapeutic potential for neurodegenerative diseases, including in prodromal stages of Parkinson's disease (PD). However, the mechanism of its protective effects has b... ...
